Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-017724
Filing Date
2018-12-20
Accepted
2018-12-20 07:32:00
Documents
58
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 789360
2 ex31-1.htm EX-31.1 17164
3 ex31-2.htm EX-31.2 17466
4 ex32-1.htm EX-32.1 9954
  Complete submission text file 0001493152-18-017724.txt   3185395

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE eton-20180930.xml EX-101.INS 379317
6 XBRL SCHEMA FILE eton-20180930.xsd EX-101.SCH 37305
7 XBRL CALCULATION FILE eton-20180930_cal.xml EX-101.CAL 38300
8 XBRL DEFINITION FILE eton-20180930_def.xml EX-101.DEF 160296
9 XBRL LABEL FILE eton-20180930_lab.xml EX-101.LAB 271978
10 XBRL PRESENTATION FILE eton-20180930_pre.xml EX-101.PRE 242371
Mailing Address 12264 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SAN DIEGO CA 92130 858-704-4040
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 181244649
SIC: 2834 Pharmaceutical Preparations